Mission Therapeutics Email Format

Biotechnology ResearchEngland, United Kingdom11-50 Employees

Mission Therapeutics is a private biotechnology company focused on drug discovery and development by selectively inhibiting deubiquitylating enzymes to treat diseases with high unmet medical need. It has built a platform to identify and develop first-in-class, small-molecule inhibitors targeting DUBs, a growing drug class attracting interest as a potential next kinase area. The firm aims to advance its pipeline through early clinical development with a patient-selection strategy intended to improve early signs of efficacy. Its leadership team has extensive international, commercial, and scientific experience, and the company maintains links with academic and research centers including Cancer Research UK Laboratories and the Jackson Laboratories at the Gurdon Institute, University of Cambridge.

Mission Therapeutics is based at the Babraham Research Campus, south of Cambridge, England. In 2024 the company entered into a collaboration with Parkinson's-focused organizations to explore MTX325 as a potential treatment for Parkinson's disease, including evaluation of safety, brain penetration, and effects on neuronal energy production.

Sign up for free to view info

Company overview Employee directory